bro help me with my final year medical thesis on the topic House Dust Mite allergies, tell me which resources to refer, n its a literature review
Reading File
Finding Sources
Finding Sources
Searching PubMed
"house dust mite" AND allergy AND immunotherapy
Searching the Web
house dust mite allergy literature review resources 2024 2025 guidelines
Reading File
Reading File
Searching PubMed
"house dust mite" AND (pathophysiology OR sensitization OR diagnosis)
I now have solid material from multiple sources. Let me compile the full resource guide for you.
House Dust Mite (HDM) Allergy - Literature Review Resource Guide
This covers what to read for each section of your thesis, from biology of the mite all the way to management. Resources are organized by theme.
1. Foundational Textbooks to Refer
These are the core references from the medical library relevant to your topic:
a) Tietz Textbook of Laboratory Medicine, 7th Ed.
- Has a dedicated section "House Dust Mite Allergy" covering: biology of Dermatophagoides farinae and D. pteronyssinus, diagnosis using SPTs + specific IgE, allergen groups (24 molecular groups), role of fecal pellets, TH2/IgE immune pathway, and CRD (component-resolved diagnostics).
- Best for: pathophysiology, diagnosis, sensitization mechanisms
b) Murray & Nadel's Textbook of Respiratory Medicine (2-Volume)
- Covers HDM sensitization in the context of asthma, lymphangiogenesis, and chronic airway inflammation models using HDM.
- Best for: asthma + HDM interaction, airway remodeling
c) Scott-Brown's Otorhinolaryngology, Head & Neck Surgery (Vol 1)
- Has a "Best Clinical Practice" section with evidence-graded points on HDM avoidance, allergen-specific immunotherapy (AIT), and evidence quality caveats.
- Best for: management, immunotherapy, allergic rhinitis
d) Cummings Otolaryngology Head and Neck Surgery
- References nasal provocation testing with HDM (Blomia tropicalis and D. pteronyssinus), useful for diagnostic methods section
e) Goldman-Cecil Medicine (International Ed.)
- Cites landmark RCTs including the JAMA 2016 sublingual HDM tablet trial (Didier et al.) - best for treatment outcomes and evidence grading
f) Firestein & Kelley's Textbook of Rheumatology
- Covers HDM extract-triggered mast cell activation via protease activity and MRGPRX2 receptor - useful for atopic dermatitis/skin manifestation mechanisms
g) Pfenninger & Fowler's Procedures for Primary Care
- Skin prick testing technique, scoring, allergen avoidance counseling for HDM - best for clinical procedures/diagnosis chapter
2. Core PubMed Papers (Peer-Reviewed, High Evidence)
Immunotherapy - Systematic Reviews & Meta-Analyses
| PMID | Paper | Why it's useful |
|---|---|---|
| 41758730 | Alqutub et al., 2026. HDM SLIT for Rhinoconjunctivitis - Comprehensive Meta-Analysis. Int Arch Allergy Immunol | Most up-to-date SLIT meta-analysis, 2026 |
| 34180463 | Kim JY et al., 2021. HDM immunotherapy in mono- vs poly-sensitised patients. Rhinology | Key for mono vs poly sensitization debate |
| 36278778 | Phinyo et al., 2022. HDM AIT - systematic review & meta-analysis. Asian Pac J Allergy Immunol | Southeast Asia patient data - relevant if your population includes Asian patients |
| 35181547 | Wongsa et al., 2022. HDM sublingual tablet in allergic asthma - RCT systematic review. J Allergy Clin Immunol Pract | SLIT specifically in asthma |
| 34464748 | Kim JY et al., 2021. SCIT vs SLIT for HDM - Network Meta-Analysis. J Allergy Clin Immunol Pract | Route comparison - great for treatment chapter |
| 37489655 | Marko & Pawliczak, 2023. Pharmacotherapy + immunotherapy of AR (HDM, grass, birch). Expert Rev Respir Med | Broad pharmacotherapy meta-analysis |
Pathophysiology, Diagnosis, Allergens
| PMID | Paper | Why it's useful |
|---|---|---|
| 37119758 | Huang HJ et al., 2023. HDM allergens: importance for diagnosis and immunotherapy. Mol Immunol | Comprehensive allergen characterization - essential for your allergen biology section |
| 34873895 | Nepolo et al., 2022. TH2-mediated inflammation in allergic reactions. Allergol Immunopathol | Mechanism of TH2 sensitization |
| 39016386 | Schoos AM, 2024. Atopic diseases - Diagnostics, mechanisms, exposures. Pediatr Allergy Immunol | Covers HDM in the context of the atopic march |
Atopic Dermatitis
| PMID | Paper | Why it's useful |
|---|---|---|
| 36191689 | Yepes-Nunez et al., 2023. AIT for atopic dermatitis. J Allergy Clin Immunol | Benefits/harms of AIT in eczema - if you cover skin manifestations |
Tropical/Special Species
| PMID | Paper | Why it's useful |
|---|---|---|
| 39577660 | Caraballo et al., 2025. Blomia tropicalis: 50-Year History. J Allergy Clin Immunol Pract | Blomia tropicalis is the dominant HDM species in tropical countries - include this if your thesis population is South Asian, Southeast Asian, or Latin American |
3. Clinical Guidelines (Must-Cite)
- ARIA-EAACI 2024-2025 Guidelines - "Allergic Rhinitis and its Impact on Asthma" - the gold standard guideline for HDM-related allergic rhinitis. PDF from EAACI/Soton
- NICE Guidance TA1045 (January 2025) - "12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites" - covers RCT evidence and cost-effectiveness. NICE draft guidance
- ICAR: Allergic Rhinitis 2023 (PMID 36878860) - International consensus statement, covers HDM extensively
- GINA Guidelines (Global Initiative for Asthma) - standard reference for HDM in asthma management
4. Suggested Literature Review Structure + What to Cite Where
Intro / Epidemiology
- Tietz Textbook (HDM prevalence, perennial allergen)
- ARIA 2024-2025 (disease burden, worldwide prevalence)
- Caraballo 2025 (if tropical focus)
Biology of HDM
- Tietz Textbook (species, life cycle, fecal pellet allergens, 24 allergen groups)
- Huang HJ 2023 (PMID 37119758) - molecular allergen characterization
Immunopathology / Mechanism
- Tietz Textbook (TH2, IgE pathway, innate immune activation)
- Nepolo et al. 2022 (TH2 meta-analysis)
- Firestein & Kelley (mast cell MRGPRX2 pathway, atopic dermatitis)
- Murray & Nadel (airway inflammation, lymphangiogenesis)
Clinical Manifestations
- Allergic rhinitis: Scott-Brown's, Cummings (ENT perspective)
- Asthma: Murray & Nadel, Goldman-Cecil
- Atopic dermatitis: Yepes-Nunez 2023
Diagnosis
- Tietz Textbook (SPT, sIgE, CRD)
- Pfenninger & Fowler (SPT technique and scoring)
- ICAR 2023 (consensus diagnostic criteria)
Management
- Allergen avoidance: Scott-Brown's (evidence caveats on avoidance)
- Pharmacotherapy: Marko & Pawliczak 2023
- SCIT vs SLIT: Kim 2021 network meta-analysis
- SLIT tablet in asthma: Wongsa 2022
- NICE 2025 (cost-effectiveness)
Future Directions
- Schoos 2024 (atopic march, early intervention)
- Zemelka-Wiacek & Jutel 2023 (PMID 38143940) - "AIT 2023: Current innovation and future outlook"
5. Key Journals to Search Directly
For a literature review, run searches in:
- Journal of Allergy and Clinical Immunology (JACI) and JACI: In Practice
- Allergy (Wiley/EAACI journal)
- Clinical & Experimental Allergy
- International Archives of Allergy and Immunology
- Asian Pacific Journal of Allergy and Immunology (if your context is South/Southeast Asia)
Use PubMed MeSH term:
"Antigens, Dermatophagoides"[MeSH] - this is the official MeSH heading for HDM allergens and will catch papers that don't use the phrase "house dust mite" directly.Quick Summary
- Your textbook backbone = Tietz, Murray & Nadel, Scott-Brown's, Goldman-Cecil
- Your pathophysiology papers = Huang HJ 2023 (PMID 37119758) + Nepolo 2022
- Your immunotherapy evidence = Kim 2021 network meta-analysis + Wongsa 2022 + Alqutub 2026
- Your guidelines = ARIA 2024-2025 + NICE TA1045 2025 + ICAR 2023
- If your thesis has a tropical/regional angle = Caraballo 2025 (Blomia tropicalis) is a unique differentiator
Good luck with the thesis! If you want, I can help you draft specific sections (intro, methods, discussion) or search for papers on any sub-topic like pediatric HDM allergy, prevention, or specific immunotherapy outcomes.
all is fine, but beginning with the introduction it must b around 3 pages, n help me find the proper articles n papers n stuff to gather info, n do help me organizing it
Finding Sources
Finding Sources
Searching PubMed
"house dust mite" AND allergy AND epidemiology AND prevalence
Searching PubMed
"Dermatophagoides" AND "allergen" AND "IgE" AND sensitization
Searching the Web
house dust mite allergy global prevalence statistics 2023 2024 allergic rhinitis asthma burden
Reading Web Page
https://www.frontiersin.org/journals/allergy/articles/10.338…
Searching PubMed
"house dust mite" AND "atopic march" AND asthma AND rhinitis
Alright, here's the full organized framework - the Introduction outline, exactly what to write in each paragraph, and the specific source to cite for every single claim.
INTRODUCTION - House Dust Mite Allergy: A Literature Review
(~3 pages | Organized into 5 paragraphs | ~800-1000 words)
PARAGRAPH 1: Opening - The Global Burden of Allergic Disease (~150-180 words)
What to write:
Start broad - establish that allergic diseases are a major global health issue. Then narrow to HDM as the leading indoor allergen.
Key facts to use:
- Allergic diseases are chronic, immune-mediated disorders resulting from hypersensitivity to environmental allergens
- Global burden: ~300 million people with asthma, ~400 million with allergic rhinitis (AR), 200-250 million with food allergies
- AR and asthma combined affect up to 800 million people worldwide (WHO)
- HDM allergy affects 4-6% of the world's population - up to 500 million people
- ~20 million affected in the USA alone; 84% of US households have detectable HDM
- In industrialized regions like Germany, 1 in 4 people are affected
Cite these sources:
| Claim | Source |
|---|---|
| Global prevalence of asthma (300M), AR (400M) | Tahir HM et al., Front Allergy 2026 - PMID 42253473 |
| 800 million AR + asthma (WHO) | Aggarwal & Senthilkumaran, StatPearls 2023 - NBK560718 |
| 500 million affected by HDM allergens (4-6% world population) | Jurkiewicz K et al., Int J Mol Sci 2025 - PMID 40565123 |
| 20M USA, 84% households | StatPearls NBK560718 |
| HDM as major perennial allergen | Tietz Textbook of Laboratory Medicine, 7th Ed. |
PARAGRAPH 2: HDM Biology and Ecology (~180-200 words)
What to write:
Introduce the mite itself - what it is, where it lives, the key species, geographic distribution, and why the tropics matter especially.
Key facts to use:
- HDM are microscopic arthropods thriving in warm, humid conditions (bedding, sofas, carpets)
- They feed on organic matter: dead skin cells and hair
- Two main species in temperate regions: D. pteronyssinus (European) and D. farinae (American/drier climates)
- These two constitute 80-90% of HDM globally
- In tropical/subtropical regions: Blomia tropicalis (family Glycyphagidae) is dominant and in some populations surpasses Dermatophagoides in sensitization rates
- First identified as a causative allergen in 1920; D. pteronyssinus specifically identified by Voorhorst et al. in 1967
- Geographic variation: climate determines which species dominates, meaning diagnosis and immunotherapy formulations need to be region-specific
Cite these sources:
| Claim | Source |
|---|---|
| Biology, species, habitat | Tietz Textbook, 7th Ed. |
| Blomia tropicalis in tropics | Tahir HM et al., Front Allergy 2026 - PMID 42253473 |
| Blomia 50-year history, tropical dominance | Caraballo L et al., JACI Pract 2025 - PMID 39577660 |
| 1920/1967 historical discovery | StatPearls NBK560718 |
| D. farinae in drier areas | Tietz Textbook + StatPearls |
| Geography affects species relevance | Tahir HM et al., Front Allergy 2026 |
PARAGRAPH 3: Allergens and Immunopathology (~200-220 words)
What to write:
The mechanism - from allergen exposure to Type 1 hypersensitivity. This is the heart of the pathophysiology. Introduce key allergens, the TH2 pathway, and the IgE cascade.
Key facts to use:
- HDM allergens are grouped into 24 groups based on molecular profile and activity
- Allergens are found in fecal particles, body proteins, and digestive enzymes
- Key allergens: Der p 1 (cysteine protease, first identified), Der p 2, Der p 23 (major allergens), Der p 10 (cross-reactive allergens)
- Type 1 hypersensitivity: CD4+ TH2 cells stimulate B cells → IgE production → IgE binds FcεRI on mast cells/basophils → sensitization → on re-exposure, cross-linking → degranulation → inflammatory mediators released
- Two main immune routes: TH2/IgE-dependent pathway + innate immune activation
- Fecal pellets also contain endotoxin, enzymes, mite and bacterial DNA - all immunostimulatory
- HLA class II loci on chromosome 6p influence individual susceptibility to Der p and Der f peptides
Cite these sources:
| Claim | Source |
|---|---|
| 24 allergen groups, fecal pellet composition | Tietz Textbook, 7th Ed. |
| Type 1 hypersensitivity pathway (IgE, mast cells) | StatPearls NBK560718 |
| Der p 1, Der p 2, Der p 23 key allergens | Jurkiewicz K et al., Int J Mol Sci 2025 - PMID 40565123 |
| TH2/innate dual route | Tietz Textbook, 7th Ed. |
| HLA loci and susceptibility | Henry's Clinical Diagnosis and Management by Laboratory Methods |
| Molecular allergen characterization | Huang HJ et al., Mol Immunol 2023 - PMID 37119758 |
PARAGRAPH 4: Clinical Manifestations and the Atopic March (~180-200 words)
What to write:
Describe what HDM allergy actually causes clinically - the spectrum from rhinitis to asthma to eczema - and the concept of the atopic march. This justifies why the topic is worth a full thesis.
Key facts to use:
- HDM is a perennial allergen (unlike seasonal pollens), causing year-round symptoms
- Clinical spectrum: allergic rhinitis → allergic asthma → atopic dermatitis
- The "atopic march": sensitization in early life progresses from eczema to rhinitis to asthma
- Up to 68.3% of children with HDM-induced AR develop symptoms by age 6
- HDM sensitization in asthmatic children rises from 53.5% (ages 0-3) to 80.2% (ages 8-12)
- In inner-city populations, HDM is recognized as a significant cause of asthma
- HDM sensitization can also trigger/worsen atopic dermatitis via mast cell MRGPRX2 activation
- Co-existence of multiple atopic conditions is common
Cite these sources:
| Claim | Source |
|---|---|
| Perennial nature, year-round symptoms | Tietz Textbook, 7th Ed. |
| Atopic march, prevalence by age | Jurkiewicz K et al., Int J Mol Sci 2025 - PMID 40565123 |
| AIT alters atopic march | Tang RB, J Chin Med Assoc 2020 - PMID 32015265 |
| Atopic dermatitis - mast cell mechanism | Firestein & Kelley's Textbook of Rheumatology |
| Asthma + HDM in inner-city populations | Fishman's Pulmonary Diseases and Disorders |
| Atopic disease co-existence | Schoos AM, Pediatr Allergy Immunol 2024 - PMID 39016386 |
PARAGRAPH 5: Rationale for the Review + Thesis Objectives (~150-170 words)
What to write:
Close the introduction by explaining the gap in knowledge and why you're writing this review. This is the "so what" paragraph.
What to argue:
- Despite high global prevalence, significant regional gaps in diagnostic and therapeutic approaches exist
- In tropical countries, Blomia tropicalis is underrepresented in standard diagnostic panels
- Diagnostic pitfalls remain (cross-reactivity, component-resolved diagnostics not universally used)
- Treatment landscape has evolved: SLIT vs. SCIT debate, emerging recombinant allergen therapies
- No universally accepted treatment algorithm tailored to all geographic populations
- This review aims to: summarize the current understanding of HDM epidemiology, immunopathology, diagnosis, and management; highlight regional variations; and evaluate current and emerging therapeutic strategies
Cite these sources:
| Claim | Source |
|---|---|
| Diagnostic pitfalls | Huber P et al., HNO 2024 - PMID 38358481 |
| Tropical gaps | Tahir HM et al., Front Allergy 2026 - PMID 42253473 |
| Future directions / gaps in AIT | Jurkiewicz K et al., Int J Mol Sci 2025 - PMID 40565123 |
| ARIA 2024-2025 guidelines gap | ARIA-EAACI 2024-2025 Guidelines |
| NICE 2025 - updated evidence | NICE TA1045 Guidance, January 2025 |
Your Master Reference List for the Introduction (12 sources)
- Tahir HM et al. (2026). A narrative review of HDM allergy: species distribution and sensitisation patterns across tropical regions. Front Allergy. PMID 42253473
- Jurkiewicz K, Jutel M, Smolinska S (2025). Update on HDM Allergy: Principal Changes over the Years. Int J Mol Sci. PMID 40565123 - Full article on PMC
- Aggarwal P, Senthilkumaran S (2023). Dust Mite Allergy. StatPearls. NBK560718 (free, always up to date)
- Huang HJ, Sarzsinszky E, Vrtala S (2023). HDM allergens: importance for diagnosis and immunotherapy. Mol Immunol. PMID 37119758
- Caraballo L, Lockey R, Puerta L (2025). Blomia tropicalis: A 50-Year History. JACI Pract. PMID 39577660
- Schoos AM (2024). Atopic diseases - Diagnostics, mechanisms, and exposures. Pediatr Allergy Immunol. PMID 39016386
- Tang RB (2020). HDM-specific immunotherapy alters the natural course of atopic march. J Chin Med Assoc. PMID 32015265
- Huber P, Becker S, Groger M (2024). Pitfalls in the diagnosis of house dust mite allergy. HNO. PMID 38358481
- Wise SK et al. (2023). ICAR: Allergic Rhinitis 2023. Int Forum Allergy Rhinol. PMID 36878860
- Tietz Textbook of Laboratory Medicine, 7th Ed. (Elsevier) - Section: House Dust Mite Allergy
- Fishman's Pulmonary Diseases and Disorders, 2-Volume Set - Chapter 45
- ARIA-EAACI Guidelines 2024-2025 - Bousquet et al. (free PDF from eprints.soton.ac.uk)
Quick Tips for Writing the Intro
- Funnel structure - start from global allergic disease burden → narrow to HDM specifically → biology → mechanism → clinical impact → why this review matters
- Every paragraph should end with a sentence that leads logically into the next paragraph
- For a final-year thesis, you want at least 8-10 citations in the intro - the list above gives you 12
- Always check which species are dominant in your country/region - if you're in South Asia, Southeast Asia, or Africa, Blomia tropicalis data from Tahir 2026 and Caraballo 2025 are very relevant and will make your intro more specific and original
- Avoid phrases like "since time immemorial" or "allergy is a very common problem" - start with a strong statistic instead
Want me to move on to the next section (Background/Literature Review body) next, or help draft the actual written text for this introduction?
This is a shared conversation. Sign in to Orris to start your own chat.